SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc is seeing increased volatility as investors weigh the company's recent acquisition of World View and multiple defense contract wins, including counter-drone security for the 2026 FIFA World Cup, against concerns over potential future dilution from a proposed increase in authorized shares. The community remains deeply divided, with bulls highlighting the firm's strengthened competitive positioning and scaling revenue, while bears express skepticism regarding share count expansion and the stock's recent price performance.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending as investors and the public react to the collapse of direct ceasefire negotiations in Pakistan, leaving the status of the Strait of Hormuz and nuclear enrichment demands unresolved. Community discourse is highly polarized, with intense debate centering on the administration's Middle East strategy, the potential for wider conflict, and growing scrutiny regarding the company's internal leadership changes.

Maulcoin

Maulcoin is surging in popularity as investors rally behind its community-driven, "no-rug" philosophy, with many holding strong in anticipation of further gains and potential airdrops. The community is actively coordinating to drive volume and increase social media visibility, framing the stock as an emerging contender against established meme coins.

ESH Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 17, 2021 and is headquartered in New York, NY.

ESH Acquisition Corp - Ordinary Shares - Class A

ESH Acquisition Corp is a focal point for the trading community due to its status as a low-float SPAC, fueling speculative discussions about potential merger activity and the likelihood of a significant price surge. Investors are intensely debating the stock's volatility, with many monitoring for signs of a short squeeze or institutional movement as the company approaches critical merger and filing deadlines.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Markets are under pressure as U.S.-Iran peace talks in Pakistan concluded without a deal, fueling uncertainty over the status of the Strait of Hormuz and energy supplies. While some community members are bracing for a volatile opening based on geopolitical risks, others remain skeptical, citing a pattern of tactical market manipulation and anticipation of further government commentary.

ASML Holding NV engages in the development, production, marketing, sales, upgrading and servicing of advanced semiconductor equipment systems. It includes lithography, metrology and inspection systems. The company was founded on April 1, 1984 and is headquartered in Veldhoven, the Netherlands.

ASML Holding NV - New York Shares

ASML Holding NV

ASML is trending as investors weigh its critical role in the global AI semiconductor supply chain against heightened geopolitical risks, particularly the potential for supply chain disruptions in the Strait of Hormuz. The community is actively debating the company's valuation versus its strategic 'bottleneck' status as a monopoly for advanced lithography equipment.

Petróleo Brasileiro SA engages in oil and gas exploration, production, and distribution activities. It operates through the following segments: Exploration and Production; Refining, Transportation, and Marketing; and Gas and Low Carbon Energies. The Exploration and Production segment covers the activities of exploration, development, and production of crude oil, natural gas liquid, and natural gas, for the primary purpose of supplying its domestic refineries. The Refining, Transportation, and Marketing segment refers to refining, logistics, transport, and trading of crude oil and oil products activities as well as exports of ethanol. The Gas and Low Carbon Energies represents the activities of logistic and trading of natural gas and electricity, transportation and trading of liquefied natural gas, generation and electricity by means of thermoelectric power plants, as well as holding interests in transporters and distributors of natural gas. The company was founded on October 3, 1953 and is headquartered in Rio de Janeiro, Brazil.

Petroleo Brasileiro S.A. Petrobras - ADR

Petroleo Brasileiro

Petroleo Brasileiro is trending as investors weigh strong production milestones and lucrative dividend yields against ongoing geopolitical volatility and shifts in regional energy policy. The community is actively debating the stock's long-term valuation in relation to global oil benchmarks and the potential impact of currency fluctuations on its ADR performance.

Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The firm focuses on portfolio of neurology, inflammation, and pain medications. Its products include INDOCIN, Sympazan, Otrexup, SPRIX, CAMBIA, and Zipsor. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.

Assertio Holdings Inc

Assertio Holdings is trending as shareholders organize to challenge the company's planned sale to Garda Therapeutics, citing deep undervaluation of the Rolvedon asset and concerns over the board's fiduciary duties. The community is actively discussing potential legal injunctions, lobbying top institutional holders, and questioning the deal structure, while sentiment remains mixed between activist opposition and skepticism regarding the board's decision-making.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is facing significant downward pressure following its latest investor day, where the company outlined a long-term roadmap to profitability by the end of the decade despite continued cash burn and production delays. While some investors see potential in the newly unveiled midsize EV platform and robotaxi initiatives, the community remains heavily divided between those betting on a major short squeeze and those increasingly skeptical of the company's ability to survive without further dilution.

iShares Inc. - iShares MSCI South Korea ETF

iShares MSCI South Korea ETF

The iShares MSCI South Korea ETF (EWY) is currently a major focus for investors acting as a proxy for the global AI infrastructure buildout, driven by explosive demand for high-bandwidth memory (HBM) chips. The community is actively debating the stock's role in the semiconductor cycle, closely monitoring earnings from top holdings like Samsung and SK Hynix while weighing risks related to geopolitical tensions, energy supply, and potential trade shifts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ocular Therapeutix (NASDAQ:OCUL) Shares Down 7.2% - Time to Sell?

Ocular Therapeutix (NASDAQ:OCUL) Trading Down 7.2% - Here's What Happened...

Ocular Therapeutix (NASDAQ:OCUL) Shares Up 9.3% - Should You Buy?

Ocular Therapeutix (NASDAQ:OCUL) Shares Up 9.3% - Still a Buy...

Ocular Therapeutix, Inc. (NASDAQ:OCUL) Short Interest Up 34.2% in March

Ocular Therapeutix, Inc. (NASDAQ:OCUL - Get Free Report) was the recipient of a significant increase in short interest in the month of March. As of March 13th, there was short interest totaling...

Assenagon Asset Management S.A. Has $7.54 Million Position in Ocular Therapeutix, Inc. $OCUL

Assenagon Asset Management S.A. grew its holdings in Ocular Therapeutix, Inc. (NASDAQ:OCUL - Free Report) by 1,261.4% during the fourth quarter, according to its most recent 13F filing with the...

Ocular Therapeutix Touts Landmark Phase 3 AXPAXLI Win at RBC Ophthalmology Conference

Ocular Therapeutix (NASDAQ:OCUL) executives highlighted what the company described as a landmark Phase 3 outcome for its retinal disease candidate AXPAXLI and discussed ongoing development, safety...

Ocular Therapeutix, Inc. (NASDAQ:OCUL) Receives Average Rating of "Moderate Buy" from Analysts

Ocular Therapeutix, Inc. (NASDAQ:OCUL - Get Free Report) has been assigned an average rating of "Moderate Buy" from the fourteen research firms that are presently covering the stock, MarketBeat...

Cantor Fitzgerald L. P. Buys Shares of 201,865 Ocular Therapeutix, Inc. $OCUL

Cantor Fitzgerald L. P. purchased a new stake in Ocular Therapeutix, Inc. (NASDAQ:OCUL - Free Report) during the third quarter, according to its most recent filing with the SEC. The firm purchased 201,865 shares of the biopharmaceutical company's stock, valued at approximately $2,360,000. Cantor Fi...

What to Make of VR Adviser's Big Ocular Therapeutix Sell-Down

Key PointsAdviser, LLC Sold 5,845,915 shares of Ocular Therapeutix; estimated transaction value $71.01 million based on quarterly average price...

Ocular Therapeutix, Inc. (NASDAQ:OCUL) Short Interest Up 20.0% in February

Ocular Therapeutix, Inc. (NASDAQ:OCUL - Get Free Report) was the recipient of a large increase in short interest during the month of February. As of February 27th, there was short interest totaling...

Ocular Therapeutix, Inc. $OCUL Shares Purchased by Avoro Capital Advisors LLC

Avoro Capital Advisors LLC grew its position in Ocular Therapeutix, Inc. (NASDAQ:OCUL - Free Report) by 38.5% in the 3rd quarter, according to its most recent disclosure with the Securities and...

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Current Price	$8.79
Prev Close	$9.30
Open	$9.31
Dividend Yield	0.00%
50-Day Moving Average	$8.83
Beta	1.46
Avg. Volume	5M
PE Ratio	-6.11

52-Week High	$16.44
52-Week Low	$6.23
Market Capitalization	$1.91B
EPS (Annual)	-$1.42
Price to Book	2.90
Revenue Per Employee	$159,849.23

OCUL
Ocular Therapeutix Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest OCUL News

OCULOcular Therapeutix Inc